Free Trial

Immunovant (IMVT) News Today

Immunovant logo
$14.36 -0.11 (-0.73%)
As of 03:38 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

IMVT Latest News

Immunovant, Inc. stock logo
Nuveen Asset Management LLC Sells 189,759 Shares of Immunovant, Inc. (NASDAQ:IMVT)
Nuveen Asset Management LLC lessened its holdings in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 17.2% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 915,151 shares of the company's stock after selling 189,759 shares dur
Immunovant, Inc. stock logo
Bank of America Corp DE Buys 114,511 Shares of Immunovant, Inc. (NASDAQ:IMVT)
Bank of America Corp DE raised its stake in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 50.4% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 341,535 shares of the company's stock after purchasing an additional 114,511 shares during the period.
Immunovant, Inc. stock logo
Woodline Partners LP Sells 772,251 Shares of Immunovant, Inc. (NASDAQ:IMVT)
Woodline Partners LP trimmed its stake in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 54.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 642,726 shares of the company's stock after
Immunovant, Inc. stock logo
Immunovant, Inc. (NASDAQ:IMVT) Shares Purchased by Two Seas Capital LP
Two Seas Capital LP raised its position in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 123.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,511,614 shares of the company's stock after acqui
Immunovant, Inc. stock logo
Rafferty Asset Management LLC Trims Stock Holdings in Immunovant, Inc. (NASDAQ:IMVT)
Rafferty Asset Management LLC reduced its stake in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 23.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 116,624 shares of the company's stock after
Immunovant, Inc. stock logo
Vestal Point Capital LP Makes New Investment in Immunovant, Inc. (NASDAQ:IMVT)
Vestal Point Capital LP acquired a new position in Immunovant, Inc. (NASDAQ:IMVT - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 45,000 shares of the company's stock, valued at approximat
Brokerages Set Immunovant, Inc. (NASDAQ:IMVT) PT at $38.33
Immunovant, Inc. stock logo
Tyro Capital Management LLC Has $3.75 Million Stock Holdings in Immunovant, Inc. (NASDAQ:IMVT)
Tyro Capital Management LLC cut its holdings in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 39.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 151,456 shares of the company's stock after selling 100,693 shares during the quarter. Immunovant comprises
Immunovant, Inc. stock logo
Immunovant, Inc. (NASDAQ:IMVT) Given Average Rating of "Moderate Buy" by Analysts
Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) has been assigned an average rating of "Moderate Buy" from the ten ratings firms that are presently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation, seven have issued a buy recommendation and
Immunovant, Inc. stock logo
Ensign Peak Advisors Inc Cuts Position in Immunovant, Inc. (NASDAQ:IMVT)
Ensign Peak Advisors Inc trimmed its stake in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 87.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 19,706 shares of the company's stock after selling
Immunovant, Inc. stock logo
BNP Paribas Financial Markets Takes Position in Immunovant, Inc. (NASDAQ:IMVT)
BNP Paribas Financial Markets acquired a new stake in Immunovant, Inc. (NASDAQ:IMVT - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 85,201 shares of the company's stock, value
Immunovant, Inc. stock logo
RTW Investments LP Purchases New Shares in Immunovant, Inc. (NASDAQ:IMVT)
RTW Investments LP purchased a new stake in Immunovant, Inc. (NASDAQ:IMVT - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 530,614 shares of the company's stock, valued at approximatel
Immunovant, Inc. stock logo
Immunovant, Inc. (NASDAQ:IMVT) Shares Bought by Northern Trust Corp
Northern Trust Corp raised its holdings in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 4.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 527,367 shares of the company's stock after purchasing an a
Immunovant, Inc. stock logo
Prosight Management LP Sells 64,477 Shares of Immunovant, Inc. (NASDAQ:IMVT)
Prosight Management LP trimmed its position in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 17.4% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 305,523 shares of the company's stock after selling 64,477 shares during the period. Immunovant accounts for a
Immunovant, Inc. stock logo
Occudo Quantitative Strategies LP Makes New Investment in Immunovant, Inc. (NASDAQ:IMVT)
Occudo Quantitative Strategies LP acquired a new stake in Immunovant, Inc. (NASDAQ:IMVT - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 34,731 shares of the company's stock, valued at appro
Immunovant, Inc. stock logo
Orbimed Advisors LLC Buys New Holdings in Immunovant, Inc. (NASDAQ:IMVT)
Orbimed Advisors LLC purchased a new position in Immunovant, Inc. (NASDAQ:IMVT - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 78,500 shares of the company's stock, val
Immunovant, Inc. stock logo
34,337 Shares in Immunovant, Inc. (NASDAQ:IMVT) Bought by J. Goldman & Co LP
J. Goldman & Co LP bought a new stake in Immunovant, Inc. (NASDAQ:IMVT - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 34,337 shares of the company's stock, valued at
Immunovant, Inc. stock logo
Granahan Investment Management LLC Makes New Investment in Immunovant, Inc. (NASDAQ:IMVT)
Granahan Investment Management LLC acquired a new stake in Immunovant, Inc. (NASDAQ:IMVT - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 149,396 shares of the company's stock, valued at approximately $3,701,000. Grana
Immunovant, Inc. stock logo
Dimensional Fund Advisors LP Sells 58,463 Shares of Immunovant, Inc. (NASDAQ:IMVT)
Dimensional Fund Advisors LP decreased its holdings in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 12.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 403,747 shares of the comp
Immunovant, Inc. stock logo
Raymond James Financial Inc. Buys Shares of 20,382 Immunovant, Inc. (NASDAQ:IMVT)
Raymond James Financial Inc. acquired a new position in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 20,382 shares of the company's stock, valued at approximately $505,000. Other
Immunovant, Inc. stock logo
DAFNA Capital Management LLC Purchases 56,000 Shares of Immunovant, Inc. (NASDAQ:IMVT)
DAFNA Capital Management LLC grew its position in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 107.7% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 107,996 shares of the compan
Immunovant, Inc. stock logo
Deep Track Capital LP Has $148.62 Million Position in Immunovant, Inc. (NASDAQ:IMVT)
Deep Track Capital LP lifted its holdings in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 38.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 6,000,000 shares of the company's stock after buying an additional 1,652,536 shares during th
Immunovant, Inc. stock logo
Hsbc Holdings PLC Invests $780,000 in Immunovant, Inc. (NASDAQ:IMVT)
Hsbc Holdings PLC purchased a new stake in Immunovant, Inc. (NASDAQ:IMVT - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 31,896 shares of the company's stock, valued at approximately $780,000. A number of other
Immunovant, Inc. stock logo
Immunovant, Inc. (NASDAQ:IMVT) Shares Acquired by Baker BROS. Advisors LP
Baker BROS. Advisors LP boosted its stake in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 39.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,707,881 shares of the company's stock after acquiring an a
Immunovant, Inc. stock logo
Boxer Capital Management LLC Makes New $20.44 Million Investment in Immunovant, Inc. (NASDAQ:IMVT)
Boxer Capital Management LLC bought a new position in Immunovant, Inc. (NASDAQ:IMVT - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 825,000 shares of the company's stock, valued at approximately $20,435,000. I
Immunovant, Inc. stock logo
Immunovant, Inc. (NASDAQ:IMVT) Shares Sold by Price T Rowe Associates Inc. MD
Price T Rowe Associates Inc. MD reduced its position in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 24.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 916,250 shares of the company's stock
Immunovant, Inc. stock logo
Aquatic Capital Management LLC Takes Position in Immunovant, Inc. (NASDAQ:IMVT)
Aquatic Capital Management LLC acquired a new position in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 47,648 shares of the company's stock, value
Immunovant, Inc. stock logo
Emerald Mutual Fund Advisers Trust Decreases Stock Holdings in Immunovant, Inc. (NASDAQ:IMVT)
Emerald Mutual Fund Advisers Trust lowered its position in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 15.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 156,097 shares of the company's stock after se
Immunovant, Inc. stock logo
Immunovant (NASDAQ:IMVT) Shares Up 3.4% - Time to Buy?
Immunovant (NASDAQ:IMVT) Stock Price Up 3.4% - What's Next?
Immunovant, Inc. stock logo
Renaissance Technologies LLC Sells 108,100 Shares of Immunovant, Inc. (NASDAQ:IMVT)
Renaissance Technologies LLC lessened its stake in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 57.2% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 80,900 shares of the company's stock after selling 108,100 shares during the period. Renaissanc
Immunovant, Inc. stock logo
Immunovant, Inc. (NASDAQ:IMVT) Shares Bought by Two Seas Capital LP
Two Seas Capital LP grew its stake in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 123.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,511,614 shares of the company's stock after purchasing an addit
Immunovant, Inc. stock logo
T. Rowe Price Investment Management Inc. Increases Stock Position in Immunovant, Inc. (NASDAQ:IMVT)
T. Rowe Price Investment Management Inc. lifted its stake in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 53.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 5,117,234 shares of the company's stock after acquiring an additional 1,786,217
Immunovant, Inc. stock logo
Canada Pension Plan Investment Board Increases Position in Immunovant, Inc. (NASDAQ:IMVT)
Canada Pension Plan Investment Board increased its stake in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 7,833.3% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 95,200 shares of the company's stock after buying an additional 94,000 shares during the q
Immunovant, Inc. stock logo
Immunovant, Inc. (NASDAQ:IMVT) Receives Average Recommendation of "Moderate Buy" from Brokerages
Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the ten ratings firms that are covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one
Immunovant, Inc. stock logo
Immunovant's (IMVT) "Neutral" Rating Reiterated at UBS Group
UBS Group reiterated a "neutral" rating and issued a $17.00 target price (down from $38.00) on shares of Immunovant in a report on Tuesday.
Immunovant, Inc. stock logo
Immunovant, Inc. (NASDAQ:IMVT) is Alpine Global Management LLC's 2nd Largest Position
Alpine Global Management LLC boosted its stake in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 14.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,158,904 shares of the company's stock after buy
Immunovant, Inc. stock logo
Immunovant (NASDAQ:IMVT) Shares Gap Down - Here's Why
Immunovant (NASDAQ:IMVT) Shares Gap Down - Here's Why
Immunovant downgraded to Neutral from Buy at UBS
UBS Downgrades Immunovant (IMVT)
Immunovant, Inc. stock logo
Immunovant, Inc. (NASDAQ:IMVT) Shares Sold by Rock Springs Capital Management LP
Rock Springs Capital Management LP decreased its stake in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 25.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 909,103 shares of the company's stock
Immunovant, Inc. stock logo
Invesco Ltd. Has $12.49 Million Holdings in Immunovant, Inc. (NASDAQ:IMVT)
Invesco Ltd. decreased its stake in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 15.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 504,032 shares of the company's stock after selling 90,210 shares
Immunovant, Inc. stock logo
Immunovant, Inc. (NASDAQ:IMVT) Short Interest Update
Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) saw a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 19,690,000 shares, an increase of 24.6% from the March 15th total of 15,800,000 shares. Currently, 28.9% of the company's stock are sold short. Based on an average daily trading volume, of 1,700,000 shares, the short-interest ratio is currently 11.6 days.
Immunovant, Inc. stock logo
22,740 Shares in Immunovant, Inc. (NASDAQ:IMVT) Acquired by XTX Topco Ltd
XTX Topco Ltd acquired a new stake in Immunovant, Inc. (NASDAQ:IMVT - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 22,740 shares of the company's stock, valued at approximately $563,000. Other hedge funds and other
Immunovant appoints Eric Venker as CEO, Girao as CFO
Immunovant, Inc. stock logo
Immunovant, Inc. (NASDAQ:IMVT) Holdings Raised by Jump Financial LLC
Jump Financial LLC increased its position in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 111.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 129,668 shares of the company's stock after purchasing an a
Get Immunovant News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMVT and its competitors with MarketBeat's FREE daily newsletter.

IMVT Media Mentions By Week

IMVT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IMVT
News Sentiment

1.50

0.78

Average
Medical
News Sentiment

IMVT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IMVT Articles
This Week

8

6

IMVT Articles
Average Week

Get Immunovant News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMVT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:IMVT) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners